A double blind randomized active-controlled clinical trial on the intra-articular use of Md-Knee versus sodium hyaluronate in patients with knee osteoarthritis (“Joint”)

Table 1 Patients’ demographic characteristics at T0

	Group A (MD-Knee) = 32	Group B (SUPARTZ®) = 32
Age (years ± SD)	69.41 ± 8.42	69.97 ± 9.5
Women, n (%)	25 (86.2 %)	20 (64.5 %)
BMI (kg/m²)	27.20 ± 3.78	27.3 ± 3.56
Kellgren and Lawrence, n (%)Grade II (%)	15 (51 %)	17 (55 %)
Kellgren and Lawrence, n (%)Grade III (%)	14 (49 %)	14 (45 %)
LKI ± SD	12.48 ± 2.63	12.6 ± 3.48
SF36 ± SD	91.41 ± 20.01	93.07 ± 17.3
Pain VAS (cm) ± SD	7.67 ± 1.41	7.42 ± 1.35

Data are mean ± SD Standard Deviation unless otherwise indicated. BMI Body Mass Index, LKI Lequesne Knee Index, VAS Visual Analogue Scale

ISSN: 1471-2474